Cardlytics (CDLX) Shares Outstanding (Weighted Average) (2016 - 2026)
Cardlytics filings provide 11 years of Shares Outstanding (Weighted Average) readings, the most recent being $54.9 million for Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 5.85% to $54.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $54.9 million through Mar 2026, up 5.85% year-over-year, with the annual reading at $53.1 million for FY2025, 9.83% up from the prior year.
- Shares Outstanding (Weighted Average) hit $54.9 million in Q1 2026 for Cardlytics, up from $53.1 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $54.9 million in Q1 2026 and bottomed at $33.4 million in Q4 2022.
- Average Shares Outstanding (Weighted Average) over 5 years is $42.6 million, with a median of $43.2 million recorded in 2024.
- The largest annual shift saw Shares Outstanding (Weighted Average) fell 0.43% in 2023 before it skyrocketed 34.83% in 2024.
- Cardlytics' Shares Outstanding (Weighted Average) stood at $33.4 million in 2022, then rose by 9.18% to $36.5 million in 2023, then soared by 32.54% to $48.4 million in 2024, then increased by 9.83% to $53.1 million in 2025, then grew by 3.36% to $54.9 million in 2026.
- Per Business Quant, the three most recent readings for CDLX's Shares Outstanding (Weighted Average) are $54.9 million (Q1 2026), $53.1 million (Q4 2025), and $52.7 million (Q3 2025).